Literature DB >> 3131472

Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages.

J Dijkstra1, J W Larrick, J L Ryan, F C Szoka.   

Abstract

We investigated the effect of lipopolysaccharide (LPS) incorporated into phospholipid vesicles (liposomes) on the induction of macrophage-mediated tumor cytotoxicity and tumor necrosis factor (TNF) secretion. The incorporation of Salmonella minnesota rough (Re)-LPS into multilamellar or small unilamellar vesicles (liposomes) resulted in an 100- to 1,000-fold reduction in its potency to activate both the macrophage cell line RAW 264.7 and murine thioglycolate elicited peritoneal macrophages to become cytotoxic for L929 and P815 tumor cells. Liposomal LPS was also a 100- to 1,000-fold less potent inducer of TNF secretion from RAW 264.7 cells. Cytokines secreted by the activated macrophages contributed to the cytotoxic effect on the L929 cells but not the P815 cell line. Human recombinant TNF was not cytotoxic for either cell line but was cytostatic for the L929 cell line. Morphological examination of the cells after uptake of fluorescent, free, and liposomal LPS revealed that both forms were internalized by the endocytic pathway. This, together with the considerably reduced potency of liposomal LPS to induce tumor cytotoxicity and TNF secretion, suggests that the interaction of the hydrophobic part of the lipid A moiety of LPS with the macrophage plasma membrane is needed to optimally activate these cells. Incorporation of LPS into liposomes effectively abrogates this interaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131472     DOI: 10.1002/jlb.43.5.436

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.

Authors:  J N Verma; M Rao; S Amselem; U Krzych; C R Alving; S J Green; N M Wassef
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.

Authors:  J Dijkstra; J W Mellors; J L Ryan
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Altered B-lymphocyte membrane architecture indicated by ganglioside accessibility in C3H/HeJ mice.

Authors:  H C Yohe; C S Berenson; C L Cuny; J L Ryan
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Monocyte cytokine secretion induced by chemically-defined derivatives of Klebsiella pneumoniae.

Authors:  Z Hmama; G Lina; C Vincent; J Wijdenes; G Normier; H Binz; J P Revillard
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

5.  Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.

Authors:  Jesús Arenas; Harry van Dijken; Betsy Kuipers; Hendrik Jan Hamstra; Jan Tommassen; Peter van der Ley
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

6.  Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.

Authors:  Nitin Joshi; Nitesh Shirsath; Ankur Singh; Kalpana S Joshi; Rinti Banerjee
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

7.  Specific features of human monocytes activation by monophosphoryl lipid A.

Authors:  Ryme Chentouh; Catherine Fitting; Jean-Marc Cavaillon
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.